HK1038380A1 - Ly6h gene - Google Patents
Ly6h geneInfo
- Publication number
- HK1038380A1 HK1038380A1 HK01109195A HK01109195A HK1038380A1 HK 1038380 A1 HK1038380 A1 HK 1038380A1 HK 01109195 A HK01109195 A HK 01109195A HK 01109195 A HK01109195 A HK 01109195A HK 1038380 A1 HK1038380 A1 HK 1038380A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- gene
- expression vector
- product
- disease
- ly6h gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26355098 | 1998-09-17 | ||
PCT/JP1999/005039 WO2000017345A1 (fr) | 1998-09-17 | 1999-09-16 | Gene ly6h |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1038380A1 true HK1038380A1 (en) | 2002-03-15 |
Family
ID=17391112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01109195A HK1038380A1 (en) | 1998-09-17 | 2001-12-28 | Ly6h gene |
Country Status (17)
Country | Link |
---|---|
US (4) | US7432363B2 (ja) |
EP (1) | EP1114861B8 (ja) |
JP (1) | JP4403443B2 (ja) |
KR (1) | KR100640265B1 (ja) |
CN (1) | CN1240834C (ja) |
AT (1) | ATE346923T1 (ja) |
AU (1) | AU767878B2 (ja) |
BR (1) | BR9913850A (ja) |
CA (1) | CA2342770C (ja) |
CY (1) | CY1107552T1 (ja) |
DE (1) | DE69934239T8 (ja) |
DK (1) | DK1114861T3 (ja) |
ES (1) | ES2276531T3 (ja) |
HK (1) | HK1038380A1 (ja) |
ID (1) | ID29573A (ja) |
PT (1) | PT1114861E (ja) |
WO (1) | WO2000017345A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1114861B8 (en) * | 1998-09-17 | 2008-10-01 | Otsuka Pharmaceutical Co., Ltd. | Ly6h gene |
CA2459161A1 (en) | 2001-08-31 | 2003-03-13 | The Rockefeller University | Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain |
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
RU2432362C2 (ru) | 2005-11-30 | 2011-10-27 | Эбботт Лэборетриз | Моноклональные антитела и их применения |
BRPI0619249A2 (pt) | 2005-11-30 | 2011-09-20 | Abbott Lab | anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
CN101663407B (zh) * | 2007-02-22 | 2017-08-08 | 健泰科生物技术公司 | 用于检测炎性肠病的方法 |
EP2486928A1 (en) | 2007-02-27 | 2012-08-15 | Abbott GmbH & Co. KG | Method for the treatment of amyloidoses |
WO2011016861A2 (en) | 2009-08-05 | 2011-02-10 | Intra-Cellular Therapies, Inc. | Novel regulatory proteins and inhibitors |
WO2011130377A2 (en) | 2010-04-15 | 2011-10-20 | Abbott Laboratories | Amyloid-beta binding proteins |
WO2012024187A1 (en) | 2010-08-14 | 2012-02-23 | Abbott Laboratories | Amyloid-beta binding proteins |
US20140286910A1 (en) * | 2013-03-19 | 2014-09-25 | Nikolai Tankovich | Stem cells and methods incorporating environmental factors as a means for enhancing stem cell proliferation and plasticity |
CN105385754B (zh) * | 2015-10-28 | 2018-11-06 | 北京泱深生物信息技术有限公司 | 一种与胆管癌相关的分子标记物 |
KR102232200B1 (ko) * | 2019-03-13 | 2021-03-25 | 아주대학교산학협력단 | 알츠하이머치매 진단 바이오마커 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5011912A (en) | 1986-12-19 | 1991-04-30 | Immunex Corporation | Hybridoma and monoclonal antibody for use in an immunoaffinity purification system |
JPH0348696A (ja) * | 1989-07-14 | 1991-03-01 | Toray Ind Inc | ヒトリンパ球表面抗原およびそれをコードする遺伝子 |
AU4594696A (en) * | 1995-11-13 | 1997-06-05 | Human Genome Sciences, Inc. | Human stem cell antigen 2 |
AU2095299A (en) * | 1997-12-31 | 1999-07-19 | Incyte Pharmaceuticals, Inc. | Human signal peptide-containing proteins |
EP1114861B8 (en) * | 1998-09-17 | 2008-10-01 | Otsuka Pharmaceutical Co., Ltd. | Ly6h gene |
-
1999
- 1999-09-16 EP EP99943357A patent/EP1114861B8/en not_active Expired - Lifetime
- 1999-09-16 DK DK99943357T patent/DK1114861T3/da active
- 1999-09-16 JP JP2000574245A patent/JP4403443B2/ja not_active Expired - Fee Related
- 1999-09-16 CA CA2342770A patent/CA2342770C/en not_active Expired - Fee Related
- 1999-09-16 PT PT99943357T patent/PT1114861E/pt unknown
- 1999-09-16 ES ES99943357T patent/ES2276531T3/es not_active Expired - Lifetime
- 1999-09-16 DE DE69934239T patent/DE69934239T8/de active Active
- 1999-09-16 BR BR9913850-6A patent/BR9913850A/pt not_active Application Discontinuation
- 1999-09-16 WO PCT/JP1999/005039 patent/WO2000017345A1/ja active IP Right Grant
- 1999-09-16 AT AT99943357T patent/ATE346923T1/de active
- 1999-09-16 AU AU56518/99A patent/AU767878B2/en not_active Ceased
- 1999-09-16 CN CNB998110191A patent/CN1240834C/zh not_active Expired - Fee Related
- 1999-09-16 KR KR1020017003354A patent/KR100640265B1/ko not_active IP Right Cessation
- 1999-09-16 ID IDW20010739A patent/ID29573A/id unknown
-
2001
- 2001-12-28 HK HK01109195A patent/HK1038380A1/xx not_active IP Right Cessation
-
2003
- 2003-12-23 US US10/743,018 patent/US7432363B2/en not_active Expired - Fee Related
-
2007
- 2007-02-02 CY CY20071100152T patent/CY1107552T1/el unknown
-
2008
- 2008-02-15 US US12/032,012 patent/US20090017479A1/en not_active Abandoned
- 2008-07-03 US US12/167,288 patent/US7582732B2/en not_active Expired - Fee Related
- 2008-09-30 US US12/242,370 patent/US20100261880A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1114861A1 (en) | 2001-07-11 |
US20090017479A1 (en) | 2009-01-15 |
DK1114861T3 (da) | 2007-03-19 |
US20100261880A1 (en) | 2010-10-14 |
EP1114861A4 (en) | 2004-10-13 |
CY1107552T1 (el) | 2013-03-13 |
WO2000017345A1 (fr) | 2000-03-30 |
KR100640265B1 (ko) | 2006-10-31 |
US20040254340A1 (en) | 2004-12-16 |
JP4403443B2 (ja) | 2010-01-27 |
US20080275218A1 (en) | 2008-11-06 |
ATE346923T1 (de) | 2006-12-15 |
CA2342770A1 (en) | 2000-03-30 |
CA2342770C (en) | 2011-06-21 |
DE69934239T2 (de) | 2007-06-28 |
PT1114861E (pt) | 2007-01-31 |
KR20010085801A (ko) | 2001-09-07 |
DE69934239T8 (de) | 2007-12-06 |
AU5651899A (en) | 2000-04-10 |
AU767878B2 (en) | 2003-11-27 |
CN1240834C (zh) | 2006-02-08 |
ID29573A (id) | 2001-09-06 |
ES2276531T3 (es) | 2007-06-16 |
CN1318099A (zh) | 2001-10-17 |
BR9913850A (pt) | 2001-10-23 |
DE69934239D1 (de) | 2007-01-11 |
EP1114861B1 (en) | 2006-11-29 |
EP1114861B8 (en) | 2008-10-01 |
US7582732B2 (en) | 2009-09-01 |
US7432363B2 (en) | 2008-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107552T1 (el) | Ly6h γονιδιο | |
WO1999053061A3 (en) | Tumor associated nucleic acids and uses therefor | |
DE69636866D1 (en) | Reverse "two-hybrid"-systeme | |
EP1005540A4 (en) | IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS | |
EP0804609A4 (en) | NEW GENES OF RESPONSE p53 | |
WO2001038486A3 (en) | Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies | |
IL135688A0 (en) | Human checkpoint kinase, hcds1, compositions and methods | |
DE69635207D1 (de) | Auf Chromosom 1 lokalisiertes Gen dessen Genprodukt mit der Alzheimerschen Krankheit assoziiert ist. | |
WO2002004677A8 (en) | Methods for diagnosis and treatment of psychiatric disorders | |
WO2000061742A3 (de) | Therapie der herzinsuffizienz durch verwendung der s100-proteinen | |
WO2000003004A3 (en) | Presenilin 2 specific ribozyme | |
WO1997002730A3 (en) | Enamel matrix related polypeptide | |
CA2245584A1 (en) | Recombinant expression of s-layer proteins | |
WO2001059120A3 (en) | Il-17 like molecules and uses thereof | |
AU6042198A (en) | Lage-1 tumor associated nucleic acids | |
WO2000071710A3 (fr) | Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol | |
WO1996038556A3 (fr) | Deltap62, ses variants, sequences d'acides nucleiques les codant, et leurs utilisations en therapie genique anti-cancereuse | |
AU5569600A (en) | Novel protein and dna thereof | |
EP0723014A3 (en) | cDNA of DOCK180 gene and DOCK180 protein | |
IL142664A0 (en) | Prv-1 gene, processes for detecting the prv-1 polypeptide and pharmaceutical compositions containing the same | |
WO2004003170A3 (en) | Agents capable of inhibiting ras and uses thereof | |
WO2000008143A3 (de) | Gen isoliert auf dem kurzen arm des menschlichen chromosoms 17 | |
EP1219706A3 (en) | Production processes for recombinant wolinella succinogenes asparaginase | |
WO2003000717A3 (de) | Identifizierung von ses-3 (spr-5) aus c. elegans sowie dessen verwendungen | |
WO2003000889A3 (de) | Identifizierung von ses-1 aus c. elegans sowie dessen verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180916 |